2018
DOI: 10.1111/cup.13113
|View full text |Cite
|
Sign up to set email alerts
|

CDX2 and LEF‐1 expression in pilomatrical tumors and their utility in the diagnosis of pilomatrical carcinoma

Abstract: This study reaffirms the importance of the Wnt signaling pathway in the tumorigenesis of pilomatrical tumors, and this introduces CDX2 as a possible regulator and marker of pilomatrical tumorigenesis. LEF-1 and CDX2 performed at least as well as β-catenin, if not better when taking into account expression pattern, as a diagnostic marker for PMCA, and should be considered in the workup of ambiguous primitive-appearing cutaneous tumors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
32
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 27 publications
(34 citation statements)
references
References 18 publications
1
32
1
Order By: Relevance
“…This staining pattern corresponds to the pattern of aberrant beta-catenin expression, suggesting involvement of activated Wnt pathway during sarcomatous transformation. The LEF-1 immunoreactivity in present case is different from the results of Tumminello et al (2018) which found that LEF-1 was strong and diffuse positive in basaloid cells of pilomatrical tumor[15]. By immunofluorescence analysis, the study ofChan et al (1999) also showed that LEF-1 expression was prominently found in nuclei of the proliferating cells of pilomatricomas[9].…”
contrasting
confidence: 94%
See 1 more Smart Citation
“…This staining pattern corresponds to the pattern of aberrant beta-catenin expression, suggesting involvement of activated Wnt pathway during sarcomatous transformation. The LEF-1 immunoreactivity in present case is different from the results of Tumminello et al (2018) which found that LEF-1 was strong and diffuse positive in basaloid cells of pilomatrical tumor[15]. By immunofluorescence analysis, the study ofChan et al (1999) also showed that LEF-1 expression was prominently found in nuclei of the proliferating cells of pilomatricomas[9].…”
contrasting
confidence: 94%
“…Mutation of exon 3 of CTNNB1, which encodes β-catenin, has also been identified in some pilomatrical neoplasms [8][9][10][11][12][13][14]. In addition, LEF1-1, further downstream effector of aberrant β-catenin in Wnt pathway, has been recently tested as a diagnostic marker for pilomatrical tumors (sensitivity = 100%, specificity = 56%) [15]. According to a small number of studies, epithelial and sarcomatous components often share partially identical chromosomal abnormalities, despite their distinct morphologies [3,16].…”
Section: Introductionmentioning
confidence: 99%
“…Tumminello and Hosler 23 found that pilomatrixomas and pilomatrix carcinomas were positive for CDX-2, β-catenin, and LEF-1 by immunohistochemistry. These downstream molecules in the Wnt signaling pathway could have the potential to be used as diagnostic and prognostic markers.…”
Section: Commentmentioning
confidence: 99%
“…These downstream molecules in the Wnt signaling pathway could have the potential to be used as diagnostic and prognostic markers. 2,13,15,23 Although the pathogenesis is unclear, there are 2 possible mechanisms by which pilomatrix carcinomas develop. They can either arise as de novo tumors, or it is possible that initial mutations in β-catenin result in the formation of pilomatrixomas at an early age that may undergo malignant transformation in elderly patients over time with additional mutations.…”
Section: Commentmentioning
confidence: 99%
“…In one study, authors assess that caudal-related homeobox transcription factor 2 (CDX2) and lymphoid enhancer-binding factor 1 (LEF-1) can be a possible regulator and marker of pilomatrical carcinoma development. CDX2 and LEF-1 performed at least as well as β-catenin 1, in which the mutation is most often described ( CTNNB1 ) ( Table 1 ) [ 9 ].…”
Section: Tumors With Follicular Differentiationmentioning
confidence: 99%